Literature DB >> 25443799

NK cells and interferons.

Rossella Paolini1, Giovanni Bernardini1, Rosa Molfetta1, Angela Santoni2.   

Abstract

The role of Natural Killer cells in host defense against infections as well as in tumour surveillance has been widely appreciated for a number of years. Upon recognition of "altered" cells, NK cells release the content of cytolytic granules, leading to the death of target cells. Moreover, NK cells are powerful producers of chemokines and cytokines, particularly Interferon-γ (IFN-γ), of which they are the earliest source upon a variety of infections. Despite being armed to fight against pathogens, NK cells become fully functional upon an initial phase of activation that requires the action of several cytokines, including type I IFNs. Type I IFNs are now recognized as key players in antiviral defense and immune regulation, and evidences from both mouse models of disease and in vitro studies support the existence of an alliance between type I IFNs and NK cells to ensure effective protection against viral infections. This review will focus on the role of type I IFNs in regulating NK cell functions to elicit antiviral response and on NK cell-produced IFN-γ beneficial and pathological effects.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiviral response; Cytotoxicity; Interferon-γ; NK cells; Type I interferon

Mesh:

Substances:

Year:  2014        PMID: 25443799     DOI: 10.1016/j.cytogfr.2014.11.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  51 in total

1.  Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer.

Authors:  Zhaoting Li; Yijia Zhu; Chenchen Li; Ryan Trinh; Xueyan Ren; Fumou Sun; Youfu Wang; Pengzhao Shang; Tong Wang; Min Wang; Sherie L Morrison; Juan Zhang
Journal:  Oncoimmunology       Date:  2017-02-17       Impact factor: 8.110

2.  Co-stimulation of the fc receptor and interleukin-12 receptor on human natural killer cells leads to increased expression of cd25.

Authors:  Megan C Duggan; Amanda R Campbell; Elizabeth L McMichael; Kallan S Opheim; Kala M Levine; Neela Bhave; Michelle C Culbertson; Tiffany Noel; Lianbo Yu; W E Carson
Journal:  Oncoimmunology       Date:  2017-10-16       Impact factor: 8.110

3.  Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection.

Authors:  C M Lin; R J Plenter; M Coulombe; R G Gill
Journal:  Am J Transplant       Date:  2016-07-07       Impact factor: 8.086

Review 4.  Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.

Authors:  S F Yanuck; J Pizzorno; H Messier; K N Fitzgerald
Journal:  Integr Med (Encinitas)       Date:  2020

5.  Differential pulmonic NK and NKT cell responses in Schistosoma japonicum-infected mice.

Authors:  Hefei Cha; Wenjuan Qin; Quan Yang; Hongyan Xie; Jiale Qu; Mei Wang; Daixiong Chen; Fang Wang; Nuo Dong; Longhua Chen; Jun Huang
Journal:  Parasitol Res       Date:  2016-11-30       Impact factor: 2.289

6.  Regulation of CX3CL1 Expression in Human First-Trimester Decidual Cells: Implications for Preeclampsia.

Authors:  S Joseph Huang; Chie-Pein Chen; Lynn Buchwalder; Ya-Chun Yu; Longzhu Piao; Chun-Yen Huang; Frederick Schatz; Charles J Lockwood
Journal:  Reprod Sci       Date:  2019-01-03       Impact factor: 3.060

Review 7.  CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.

Authors:  Joseph D Malaer; Porunelloor A Mathew
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

8.  TNFα Augments Cytokine-Induced NK Cell IFNγ Production through TNFR2.

Authors:  Wagdi Almishri; Tania Santodomingo-Garzon; Tyson Le; Danuta Stack; Christopher H Mody; Mark G Swain
Journal:  J Innate Immun       Date:  2016-08-25       Impact factor: 7.349

9.  A broadly neutralizing human monoclonal antibody is effective against H7N9.

Authors:  Kannan Tharakaraman; Vidya Subramanian; Karthik Viswanathan; Susan Sloan; Hui-Ling Yen; Dale L Barnard; Y H Connie Leung; Kristy J Szretter; Tyree J Koch; James C Delaney; Gregory J Babcock; Gerald N Wogan; Ram Sasisekharan; Zachary Shriver
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

10.  Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses.

Authors:  Maud Charpentier; Elena Garcia-Martinez; Karsten A Pilones; Camille Daviaud; Jeffrey Kraynak; Joseph Aryankalayil; Silvia C Formenti; Sandra Demaria
Journal:  Cancer Immunol Res       Date:  2020-06-12       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.